SCHEMBL2300754

SCHEMBL2300754

Nc1ccc(-c2cc(N3CCNC3=O)ccc2S(=O)(=O)O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
NT5E P21589 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
EIF2AK2 P19525 1/20 0.34
TDO2 P48775 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
GNG2 P59768 2/20 0.32
GNB1 P62873 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CCNA2 P20248 3/20 0.32
CDK2 P24941 3/20 0.32
CCNA1 P78396 3/20 0.32
ALOX5AP P20292 3/20 0.32
FEN1 P39748 3/20 0.32
SUV39H2 Q9H5I1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2303530 0.90 PDK2 (0.34) EIF2AK2TDO2CCNA2CDK2CCNA1
SCHEMBL2307068 0.90 TDO2 (0.40) ALDH1A1EIF2AK2TDO2ALOX5APFEN1
SCHEMBL2306916 0.89 TDO2 (0.35) EIF2AK2TDO2CCNA2CDK2CCNA1
SCHEMBL2236723 0.89 KMT2A (0.34) ALDH1A1EIF2AK2TDO2CCNA2CDK2
SCHEMBL2297980 0.89 PKM (0.36) EIF2AK2TDO2CYP2C9SUV39H2LMNA
SCHEMBL2303927 0.89 EIF2AK2 (0.43) ALDH1A1EIF2AK2CYP2C9CCNA2CDK2
SCHEMBL2303035 0.88 CALML3 (0.38) EIF2AK2TDO2CCNA2CDK2CCNA1
SCHEMBL2301978 0.87 ALDH1A1 (0.38) ALDH1A1TSHRDDB1CRBNEIF2AK2
SCHEMBL2304343 0.86 CCNA2 (0.33) ALDH1A1EIF2AK2TDO2CCNA2CDK2
SCHEMBL2307898 0.86 LMNA (0.36) ALDH1A1EIF2AK2CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 ALDH1A1 1937/4885TSHR 171/4885NT5E 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.